Recombinant Anti-Histone H3 (K27M mutant) Antibody [RM192] (A121298)

Immunostaining of brain tumor tissue sections, using both EDTA and Citrate pretreatment methods, with Anti-Histone H3 (K27M mutant) Antibody [RM192]. Clinically validated to be Positive for the H3.3 K27M Mutation by Sanger sequencing.

Immunostaining of brain tumor tissue sections, using both EDTA and Citrate pretreatment methods, with Anti-Histone H3 (K27M mutant) Antibody [RM192]. Clinically validated to be Negative for the H3.3 K27M Mutation by Sanger sequencing.

Western blot analysis of cell lysates prepared from 293T transfected with a DNA construct encoding wild type (WT) or K27M mutant proteins of Histone H3.3, using 0.01µg/ml of Anti-Histone H3 (K27M mutant) Antibody [RM192].

Immunohistochemical staining of formalin fixed and paraffin embedded 293T cells transfected with a DNA construct encoding Histone H3 K27M mutant, stained with 0.01µg/ml of Anti-Histone H3 (K27M mutant) Antibody [RM192].